JCS -- Lawrenson et al. 115 (5): 1059 Figure IG7

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 7. Dominant-negative SH3^* CrkII abrogates ephrin-A5-mediated cytoskeletal changes. EphA3 293T cells (control) were transiently transfected with myc-tagged, w/t CrkII, dominant-negative SH3^* CrkII or both w/t and SH3^* CrkII as indicated. Parallel cultures of stimulated (+) or nonstimulated (-) cells were fixed in 4% PFA. Cells were stained with rhodamine-phalloidin (Phalloidin) or anti-Myc antibody (anti-Myc) to monitor the actin cytoskeleton or CrkII derived proteins, respectively.